Working in cooperation with MediClin should result in local advantages
After a successful in 2011, the Asklepios Group closed the business year, maintaining its position as one of the leading hospital concerns in Germany. Thereby, the share in MediClin public limited company was increased to over 52 percent. Supported by high organic growth, the group recorded a patient increase of 9.1 percent to more than 1.7m patients. Correspondingly, sales increased by twelve percent to 2,577m Euro (previous year: 2,280m Euro).